Weng Lin Tang

Title: Weng Lin Tang: Innovator in Biocatalysis

Introduction

Weng Lin Tang is a prominent inventor based in Singapore, known for his significant contributions to the field of biocatalysis. With a total of 12 patents to his name, he has made remarkable advancements in the synthesis of chiral amines and substituted lactams. His work is pivotal in the development of active pharmaceutical agents.

Latest Patents

Weng Lin Tang's latest patents include "Engineered biocatalysts and methods for synthesizing chiral amines." This patent provides engineered transaminase polypeptides for the production of amines, along with polynucleotides encoding these engineered transaminases. It also details host cells capable of expressing the engineered transaminases and methods for using them to prepare compounds useful in the production of active pharmaceutical agents. Another notable patent is "Biocatalysts and methods for the synthesis of substituted lactams," which relates to transaminase polypeptides capable of aminating a dicarbonyl substrate, along with polynucleotides, vectors, host cells, and methods for making and using these transaminase polypeptides.

Career Highlights

Weng Lin Tang is currently associated with Codexis, Inc., where he continues to innovate and develop new biocatalytic processes. His expertise in the field has positioned him as a key player in advancing biocatalysis technologies.

Collaborations

Weng Lin Tang has collaborated with notable colleagues, including Helen Hsieh and Son Pham, contributing to various projects that enhance the capabilities of biocatalysts in pharmaceutical applications.

Conclusion

Weng Lin Tang's work in biocatalysis exemplifies the innovative spirit of modern science. His patents and collaborations reflect a commitment to advancing the field and improving pharmaceutical production methods.